COVID-19 vaccine inequity in African low-income countries.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 02 11 2022
accepted: 14 02 2023
entrez: 23 3 2023
pubmed: 24 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Equitable access and utilization of the COVID-19 vaccine is the main exit strategy from the pandemic. This paper used proceedings from the Second Extraordinary Think-Tank conference, which was held by the Health Economics and Policy Unit at the Kamuzu University of Health Sciences in collaboration with the Malawi Ministry of Health, complemented by a review of literature. We found disparities in COVID-19 vaccine coverage among low-income countries. This is also the case among high income countries. The disparities are driven mainly by insufficient supply, inequitable distribution, limited production of the vaccine in low-income countries, weak health systems, high vaccine hesitancy, and vaccine misconceptions. COVID-19 vaccine inequity continues to affect the entire world with the ongoing risks of emergence of new COVID-19 variants, increased morbidity and mortality and social and economic disruptions. In order to reduce the COVID-19 vaccination inequality in low-income countries, there is need to expand COVAX facility, waive intellectual property rights, transform knowledge and technology acquired into vaccines, and conduct mass COVID-19 vaccination campaigns.

Identifiants

pubmed: 36950103
doi: 10.3389/fpubh.2023.1087662
pmc: PMC10025287
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1087662

Informations de copyright

Copyright © 2023 Kunyenje, Chirwa, Mboma, Ng'ambi, Mnjowe, Nkhoma, Ngwira, Chawani, Chilima, Mitambo, Crampin and Mfutso-Bengo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Public Health. 2022 Mar 07;10:821117
pubmed: 35321196
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):335-340
pubmed: 35239636
NPJ Vaccines. 2021 Apr 14;6(1):54
pubmed: 33854072
Vaccines (Basel). 2022 Dec 20;11(1):
pubmed: 36679856
PLoS Med. 2021 Sep 13;18(9):e1003772
pubmed: 34516558
Rand Health Q. 2022 Aug 31;9(4):1
pubmed: 36238007
BMJ Open. 2021 Dec 15;11(12):e055159
pubmed: 34911723
PLoS One. 2021 Dec 1;16(12):e0260575
pubmed: 34851998
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
J Law Med Ethics. 2020 Sep;48(3):622-626
pubmed: 33021168
Cell Host Microbe. 2021 Jul 14;29(7):1036-1039
pubmed: 34265241
Arch Med Res. 2021 Oct;52(7):761-763
pubmed: 33941393

Auteurs

Chifundo Annessia Kunyenje (CA)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Gowokani Chijere Chirwa (GC)

Department of Economics, Chancellor College, University of Malawi, Zomba, Malawi.

Sebastian M Mboma (SM)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Wingston Ng'ambi (W)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Emmanuel Mnjowe (E)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Dominic Nkhoma (D)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Lucky Gift Ngwira (LG)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Marlen Stacey Chawani (MS)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.
Malawi Liverpool Wellcome Programme, Policy Unit, Lilongwe, Malawi.

Ben Chilima (B)

Ministry of Health, Public Health Institute of Malawi, Lilongwe, Malawi.

Collins Mitambo (C)

Ministry of Heath, Research Directorate, Lilongwe, Malawi.

Amelia Crampin (A)

Malawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.

Joseph Mfutso-Bengo (J)

Department of Health Systems, Health Economics and Policy Unit, Kamuzu University of Health Sciences (KUHeS), Lilongwe, Malawi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH